Improve trunk posture and balance
- Trial ID
- NCT07610031
- Official Title
- Effects of Trunk Control Exercises and Mirror Therapy on Balance and Posture in Patients With Parkinson's Disease
- Goal
- Improve trunk posture and balance
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- University of Lahore
- Study Type
- INTERVENTIONAL
- Enrollment
- 36 participants
- Conditions
- Parkinson s Disease
- Interventions
- Trunk control exercise, Mirror therapy
Summary For Families
Aiming to reduce balance problems and poor trunk posture that can cause falls and a stooped gait in Parkinson's, this trial tests whether focused core training plus visual feedback can improve upright stability. It combines trunk control exercises to strengthen and coordinate the core muscles that support posture, with mirror therapy that provides visual feedback to retrain movement symmetry and motor patterns; these are rehab approaches meant to complement, not replace, a person’s usual Parkinson’s medications. Looking for people aged 50 to 70 with mild to moderate Parkinson’s (Hoehn and Yahr stages 1,3), on a fixed medication dose, with normal cognition (Mini‑Mental score 24,30), able to rise from a chair without help, and without major dyskinesias, recent seizures or trauma, or unstable cardiovascular disease.
Locations
- Nimra Nadeem, Lahore, Punjab Province, Pakistan
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Trunk control exercise. Aiming to reduce balance problems and poor trunk posture that can cause falls and a stooped gait in Parkinson's, this trial tests whether focused core training plus visual feedback can improve upright stability. It combines trunk control exercises to strengthen and coordinate the core muscles that support posture, with mirror therapy that provides visual feedback to retrain movement symmetry and motor patterns; these are rehab approaches meant to complement, not replace, a person’s usual Parkinson’s medications. Looking for people aged 50 to 70 with mild to moderate Parkinson’s (Hoehn and Yahr stages 1,3), on a fixed medication dose, with normal cognition (Mini‑Mental score 24,30), able to rise from a chair without help, and without major dyskinesias, recent seizures or trauma, or unstable cardiovascular disease.
- Who can participate?
- Participants must be between 50 Years and 70 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 6 months.
- Will I get the real drug or a placebo?
- It depends on the trial design. Some Parkinson's trials are placebo controlled, meaning a portion of participants get an inactive comparison while others get the experimental treatment. Some use crossover designs so everyone eventually receives the active treatment at some point. Observational trials do not use a placebo at all because they are not testing a new treatment. The consent form for any specific trial spells out the design and your odds of being assigned to placebo before you enroll.
- How often will I need to visit the study site?
- Visit frequency varies by trial. Many Parkinson's studies require an in person visit every 4 to 12 weeks during the active treatment phase, with shorter or longer gaps depending on the design. The site coordinator can give you the full visit schedule before you sign anything, so you know what the time commitment looks like.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Will travel or parking be reimbursed?
- Many trials reimburse for parking, mileage, and sometimes lodging if the site is far from your home. Reimbursement policies vary by sponsor and site. When you contact the trial team, ask specifically what is covered and how reimbursement is processed.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.